Johnson & Johnson Seed Grant Funding
NTEC together with DFW partners is pleased to announce that we
are accepting proposals to compete for Johnson & Johnson's seed
grant program of up to $250K of non-dilutive funding.
The Program:
The Johnson & Johnson Corporate Office of Science and
Technology ("COSAT", https://www.jnjcosat.com/cosat)
is an umbrella organization within Johnson & Johnson that
monitors new developments in science and technology in terms of
their relevance to the strategic interests of the J&J family of
companies, spanning medical devices, diagnostics, biotechnology,
and consumer products. On a periodic basis, the Emerging
Technologies Group within COSAT organizes a focused day to review
early stage opportunities from each region to consider such
opportunities for a non-dilutive seed grant funding program
available through COSAT. The awardees could potentially
benefit from this program in a few ways:
- seed (non dilutive) funding (which is usually capped at around
$250K)
- access to J&J's internal experts in the relevant
domain
- enhanced visibility in the investment community by virtue of
J&J's support
How to Participate:
Interested companies should submit a non-confidential
abstract/executive summary of their start-up opportunity for
COSAT's pre-screening review to Hubert Zajicek (hzajicek@ntec-inc.org) by
Midnight, SATURDAY, January 28th, 2012. Projects of strategic
interest to J&J will be invited to hold a 45-50 minute
non-confidential meeting individually with the COSAT reviewers in
North Texas towards the end of February at NTEC (exact day
TBD). Half of this time is intended to be spent on the
project presentation and half on an informal Q&A session. Your
submission will also be considered by NTEC's Venture Alliance &
Investment partners. Should you not want this submission to be
considered by other funders, let us know at time of
submittal.
The North Texas community can work together to get great deal flow
for this event and get some North Texas start-ups funded!
